Asia Investors Landscape Workshop

This workshop will provide an overview of the investment landscape in Asia and elucidate various categories of investor groups. Senior research staff at Life Science Nation will share tips on researching and building relationship with these investors.

Presenters

Michael Quigley, VP of Investor Research, Life Science Nation

Michael Quigley is the VP of Market Research for LSN in Boston, Massachusetts. He has been with the company for 4 years, researching life science investors from around the globe. In addition to managing a team of research analysts in the US and abroad, Michael uses his global reach and understanding of the early stage investor arena to make LSN’s Redefining Early Stage Investment Conference series one of the most compelling life science conferences today. He is a key contributor in designing content and selecting dynamic relevant topics and recruiting world renown investors. Michael and his team also assist in preparing global investor target lists for LSN and Boston Innovation Capital clients. Michael also participates in the planning and execution of global investor road shows. Michael and his team also create content for LSN’s Next Phase weekly Newsletter, he and his team write about their latest observations from the life science private investment ecosystem. Michael earned his bachelor’s degree in Economics and Finance at Bentley University.

Christine Wu, Senior Research Analyst, Life Science Nation

Christine Wu is a seasoned R&D specialist with an extensive background in neuroscience and psychology. Christine served as a Research Assistant in the Stress Neurobiology Division at the Children’s Hospital of Philadelphia, analyzing the biological and behavioral effects of stress, depression, and anxiety in behavioral models including sleep-deprivation. She continued her research experience in oncology at SENS Research Foundation in Mountain View, CA, where she optimized the assay for the Alternative Lengthening of Telomeres (ALT) cancer pathway and performed high-throughput high-content data analysis to distinguish drug effectiveness. As part of the Precision Medicine Group at Pfizer, Christine performed a gene chip study for IBD and Crohn’s Disease patients. Currently, Christine is a Senior Research Analyst at Life Science Nation (LSN) where she collaborates with investors with a life science focus on therapeutics, medical devices, diagnostics, and healthcare IT. Christine received her B.A. in Biological Basis of Behavior and Creative Writing from the University of Pennsylvania and Healthcare Services & Management from The Wharton School.

Go Back to Agenda